Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
SLGN vs ATR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ATR Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)
ATR Overall Winner
6-Pillar Tally: SLGN 1 – 5 ATR
Matrix Metrics: SLGN 3 – 7 ATR
As of Nov 17, 2026, AptarGroup, Inc. (ATR) is the stronger overall head-to-head candidate over Silgan Holdings Inc (SLGN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SLGN carries a Unified Composite Score of 32.3/100 (SELL) at $40.30 (10.1x Forward P/E, 9.7% operating margin), whereas ATR carries 39.6/100 (SELL) at $140.93 (23.1x Forward P/E, 12.4% operating margin).
- Defensive Composite Rating Caution: Although ATR compares more favorably head-to-head, both SLGN (32.3/100 SELL) and ATR (39.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About SLGN vs ATR
SLGN
Silgan Holdings Inc
$40.30
-0.99% 1D
Market Cap
$4.3B
TTM Revenue
$6.71B
Forward P/E
10.1x
Beta / 30D Vol
0.60β · 34% Vol
Unified Composite Score
32.3
SELL
Tech 34.0
Fund 42.0
Flow 54.0
Mom 36.0
Weinstein Technical Phase
Neutral · Hold
ATR
Head-to-Head Winner
AptarGroup, Inc.
$140.93
-1.57% 1D
Market Cap
$9.1B
TTM Revenue
$3.99B
Forward P/E
23.1x
Beta / 30D Vol
0.34β · 30% Vol
Unified Composite Score
39.6
SELL
Tech 24.0
Fund 37.0
Flow 54.0
Mom 31.1
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (SLGN 1 – 5 ATR)
1. Valuation Multiples
SLGN
Forward P/E
10.1x
23.1x
Trailing P/E
16.5x
34.6x
PEG Ratio
0.84x
3.14x
EV / Revenue
1.3x
2.6x
2. Growth & Scale
ATR
Revenue Growth (YoY)
+1.6%
+6.0%
Earnings Growth (YoY)
-6.6%
-73.4%
TTM Revenue (USD)
$6.71B
$3.99B
Market Cap
$4.3B
$9.1B
3. Profitability & Quality
ATR
Gross Margin
17.0%
35.8%
Operating Margin
9.7%
12.4%
Net Profit Margin
3.9%
6.7%
Return on Equity (ROE)
11.0%
9.8%
4. Balance Sheet & Cash Flow
ATR
Cash Generation (TTM)
$347M
$801M EBITDA
Cash Flow Margin
5.2%
20.1% EBITDA Mgn
Net Cash / Leverage
$4.22B Net Debt (1.84x D/E)
$1.21B Net Debt (0.54x D/E)
Dividend Yield
2.04%
1.35%
5. Options & Positioning
ATR
Options Structure Phase
CONSOLIDATION
SURGE
Current IV / %ile
25.4% (12th %ile)
24.6% (22nd %ile)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
DISTRIBUTION · Neutral
DISTRIBUTION · Markup
6. R&D & Supply-Chain Moat
ATR
OpEx & R&D Intensity
7.3% of Rev ($490M)
23.4% of Rev ($934M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Packaging & Containers Operator
Medical Instruments & Supplies Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: SLGN (3) vs ATR (7)| Institutional Metric | SLGN | ATR | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $4.3B | $9.1B | ATR | |
| Trailing P/E Ratio | 16.5x | 34.6x | SLGN | |
| Forward P/E Ratio | 10.1x | 23.1x | SLGN | |
| Revenue Growth (YoY) | +1.6% | +6.0% | ATR | |
| Operating Margin (TTM) | 9.7% | 12.4% | ATR | |
| Net Profit Margin | 3.9% | 6.7% | ATR | |
| Return on Equity (ROE) | 11.0% | 9.8% | SLGN | |
| 52-Week Range Position | 42% ($34–$50) | 80% ($111–$149) | ATR | |
| Beta / 30D Volatility | 0.60β · 34% Vol | 0.34β · 30% Vol | ATR | |
| Unified Institutional Score | 32.3 / 100 (SELL) | 39.6 / 100 (SELL) | ATR | |
| Trailing 12M Revenue (USD) | $6.71B | $3.99B | Scale | |
| Gross Profit Margin (TTM) | 17.0% | 35.8% | Quality | |
| PEG Ratio & EV / Revenue | 0.84x PEG · 1.3x EV/Rev | 3.14x PEG · 2.6x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $347M ($4.22B Net Debt (1.84x D/E)) | $801M EBITDA ($1.21B Net Debt (0.54x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
ATR +12.46 pp
3M Horizon
ATR +8.16 pp
6M Horizon
ATR +15.37 pp
1Y Horizon
ATR +12.72 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SLGN Revenue | ATR Revenue | SLGN Op. Margin | ATR Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $4.45B | $2.76B | 9.3% | 10.4% | ATR |
| FY2019 | $4.49B | $2.86B | 8.0% | 13.0% | ATR |
| FY2020 | $4.92B | $2.93B | 6.3% | 11.6% | ATR |
| FY2021 | $5.68B | $3.23B | 6.3% | 10.8% | ATR |
| FY2022 | $6.41B | $3.32B | 5.3% | 11.4% | ATR |
| FY2023 | $5.99B | $3.49B | 5.4% | 11.6% | ATR |
| FY2024 | $5.85B | $3.58B | 4.7% | 13.9% | ATR |
| FY2025 | $6.48B | $3.78B | 4.4% | 13.3% | ATR |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
SLGN
CONSOLIDATION
Current IV
25.4%
IV Percentile
12th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact SLGN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
ATR
SURGE
Current IV
24.6%
IV Percentile
22nd %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BEARISH
OBV Flow
DISTRIBUTION
Exact ATR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
SLGN Moat Profile
Cyclical / Execution-Driven Positioning
Packaging & Containers Operator
OpEx & R&D Reinvestment
7.3% of Rev ($490M)
90D Engineering Disclosures
0 Published
ATR Moat Profile
Cyclical / Execution-Driven Positioning
Medical Instruments & Supplies Operator
OpEx & R&D Reinvestment
23.4% of Rev ($934M)
90D Engineering Disclosures
0 Published
Investor FAQ SLGN vs ATR Key Questions & Quantitative Answers
As of Nov 17, 2026, AptarGroup, Inc. (ATR) is the stronger overall head-to-head candidate over Silgan Holdings Inc (SLGN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). SLGN carries a Unified Composite Score of 32.3/100 (SELL) at $40.30 (10.1x Forward P/E, 9.7% operating margin), whereas ATR carries 39.6/100 (SELL) at $140.93 (23.1x Forward P/E, 12.4% operating margin). Defensive Composite Rating Caution: Although ATR compares more favorably head-to-head, both SLGN (32.3/100 SELL) and ATR (39.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
ATR leads the Growth & Scale pillar: SLGN posts +1.6% YoY revenue growth and -6.6% YoY earnings growth on $6.71B TTM revenue (17.0% gross margin, 9.7% operating margin), compared with ATR at +6.0% YoY revenue growth and -73.4% YoY earnings growth on $3.99B TTM revenue (35.8% gross margin, 12.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SLGN cumulative revenue shifted +45.6% while ATR shifted +37.0%. In operating R&D and SG&A reinvestment, SLGN deploys 7.3% of Rev ($490M) (0 90-day corporate R&D disclosures) versus 23.4% of Rev ($934M) (0 disclosures) for ATR.
SLGN screens cheaper on headline valuation multiples. SLGN trades at 10.1x Forward P/E, 16.5x Trailing P/E, 0.84x PEG, and 1.3x EV/Revenue (5.2% FCF margin), whereas ATR trades at 23.1x Forward P/E, 34.6x Trailing P/E, 3.14x PEG, and 2.6x EV/Revenue (20.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SLGN (11.0% ROE) versus ATR (9.8% ROE) capital efficiency.
In options market volatility and institutional positioning, SLGN carries 25.4% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.60β · 34% Vol realized risk). By comparison, ATR carries 24.6% implied volatility (22nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.34β · 30% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
ATR vs SLGN · Reverse Pair
SLGN vs SON
· Sector Peer
SLGN vs GEF
· Sector Peer
SLGN vs CCK
· Sector Peer
ATR vs DCI
· Sector Peer
ATR vs CSL
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem